tiprankstipranks
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market

Oncolys BioPharma, Inc. (4588) Financial Statements

Compare
0 Followers

Oncolys BioPharma, Inc. Financial Overview

Oncolys BioPharma, Inc.'s market cap is currently ¥15.15B. The company's EPS TTM is ¥-77.179; its P/E ratio is ―; Oncolys BioPharma, Inc. is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 63.04M¥ 976.18M¥ 642.49M¥ 314.18M¥ 1.30B
Gross Profit¥ 30.61M¥ 338.49M¥ 198.80M¥ 236.11M¥ 1.19B
Operating Income¥ -1.93B¥ -1.20B¥ -1.45B¥ -1.67B¥ -511.46M
EBITDA¥ -1.93B¥ -1.14B¥ -1.60B¥ -2.08B¥ -901.53M
Net Income¥ -1.94B¥ -1.15B¥ -1.62B¥ -2.10B¥ -912.35M
Balance Sheet
Cash & Short-Term Investments¥ 1.53B¥ 1.71B¥ 3.45B¥ 2.07B¥ 3.34B
Total Assets¥ 2.04B¥ 2.65B¥ 4.29B¥ 2.80B¥ 4.38B
Total Debt¥ 315.17M¥ 393.66M¥ 503.47M¥ 525.08M¥ 528.22M
Net Debt¥ -972.59M¥ -1.32B¥ -2.95B¥ -1.54B¥ -2.81B
Total Liabilities¥ 566.50M¥ 491.69M¥ 697.88M¥ 793.09M¥ 926.01M
Stockholders' Equity¥ 1.47B¥ 2.16B¥ 3.59B¥ 2.00B¥ 3.45B
Cash Flow
Free Cash Flow¥ -1.34B¥ -1.72B¥ -1.74B¥ -1.47B¥ -242.52M
Operating Cash Flow¥ -1.34B¥ -1.72B¥ -1.74B¥ -1.47B¥ -238.23M
Investing Cash Flow¥ -5.39M¥ 20.12M¥ -942.00K¥ -37.58M¥ -4.44M
Financing Cash Flow¥ 1.14B¥ -113.83M¥ 3.09B¥ 242.26M¥ 1.12B
Currency in JPY

Oncolys BioPharma, Inc. Earnings and Revenue History

Oncolys BioPharma, Inc. Debt to Assets

Oncolys BioPharma, Inc. Cash Flow

Oncolys BioPharma, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis